Novel streptogramin antibiotics (Q34141055)

31 July 2017

1 reference

title

Novel streptogramin antibiotics (English)

1 reference

31 July 2017

0 references

Bonfiglio G

1

1 reference

31 July 2017

Furneri PM

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

Expert Opinion on Investigational Drugs

31 July 2017

published in

1 reference

31 July 2017

volume

10

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

185-198

1 reference

The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomes

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Analysis of the reversible binding of virginiamycin M to ribosome and particle functions after removal of the antibiotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Erythromycin resistance by ribosome modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Insights into erythromycin action from studies of its activity as inducer of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Evidence for functional interaction between domains II and V of 23S ribosomal RNA from an erythromycin-resistant mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Identification of a site on 23S ribosomal RNA located at the peptidyl transferase center

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Conformational alteration of mRNA structure and the posttranscriptional regulation of erythromycin-induced drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Posttranscriptional modification of mRNA conformation: mechanism that regulates erythromycin-induced resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Transcriptional attenuation control of ermK, a macrolide-lincosamide-streptogramin B resistance determinant from Bacillus licheniformis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Sequence of a staphylococcal gene, vat, encoding an acetyltransferase inactivating the A-type compounds of virginiamycin-like antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Diversity among the gram-positive acetyltransferases inactivating streptogramin A and structurally related compounds and characterization of a new staphylococcal determinant, vatB

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Nucleotide sequence of a staphylococcal plasmid gene, vgb, encoding a hydrolase inactivating the B components of virginiamycin-like antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Sequence of a staphylococcal plasmid gene, vga, encoding a putative ATP-binding protein involved in resistance to virginiamycin A-like antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Characterization of a new staphylococcal gene, vgaB, encoding a putative ABC transporter conferring resistance to streptogramin A and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Characterization of a variant of vga(A) conferring resistance to streptogramin A and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Resistance to glycopeptides in enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

In vitro activity of RP 59500 (quinupristin/dalfopristin) and ramoplanin against vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and Enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Distribution and antibiotic resistance of isolates from lower respiratory tract and blood cultures from patients in three Italian intensive care units: a 2-year comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Lysogenic conversion as a factor influencing the vancomycin tolerance phenomenon in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Comparative activity of eighteen antimicrobial agents against anaerobic bacteria isolated in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Quinupristin/dalfopristin: spectrum of activity, pharmacokinetics, and initial clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.185

10.1517/13543784.10.2.185

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference